The Claim

Exposure to high glucose, advanced glycation end products, and interleukin-1 beta in a microphysiological arterial model containing collagen, endothelial cells, and vascular smooth muscle cells induces measurable cellular changes and alters cytokine and nitric oxide levels.

Source: Investigation of the Dysfunction Caused by High Glucose, Advanced Glycation End Products, and Interleukin‐1 Beta and the Effects of Therapeutic Agents on the Microphysiological Artery Model

What the research says

Not yet evaluated

We are still looking at what the research says.

Supports
0score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In a laboratory model of human arteries made of collagen, endothelial cells, and smooth muscle cells, high glucose, advanced glycation end products, and interleukin-1 beta cause measurable changes in cell behavior and change the levels of cytokines and nitric oxide.

See the scientific wording

Exposure to high glucose, advanced glycation end products, and interleukin-1 beta in a microphysiological arterial model composed of collagen, endothelial cells, and vascular smooth muscle cells induces measurable cellular changes and alters cytokine and nitric oxide levels, suggesting these factors contribute to vascular dysfunction under diabetic conditions.

Why this might work

Too much sugar and toxic sugar-protein mixtures in the blood trigger cells in artery walls to produce harmful molecules called reactive oxygen species. These molecules activate inflammation signals and block the production of a vital molecule called nitric oxide, which keeps blood vessels relaxed and healthy. The inflammation signal IL-1β makes this worse. As a result, the artery cells change shape, the lining becomes damaged, and the vessel loses its ability to function properly.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Investigation of the Dysfunction Caused by High Glucose, Advanced Glycation End Products, and Interleukin‐1 Beta and the Effects of Therapeutic Agents on the Microphysiological Artery Model

    In a tiny lab-grown model of an artery, scientists made it act like a diabetic artery by adding too much sugar, toxic sugar-protein mixtures, and an inflammation signal — and saw clear changes in cell behavior and chemicals. This matches what the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.